Virtual screening for beta-lactamase inhibitors
Another paper from the Brenk group published.
Our paper about virtual screening for GES-5 inhibitors has been published in a special issue in Biomolecules. This was a collaborative work initiated by Donatella Tondi from the University of Modena.
Klein R, Cendron L, Montanari M, Bellio P, Celenza G, Maso L, Tondi D, Brenk R. Targeting the Class A Carbapenemase GES-5 via Virtual Screening. Biomolecules. 2020 Feb 14;10(2). pii: E304.[Pubmed | DOI]